By Michele Maatouk
Date: Thursday 10 Oct 2019
(Sharecast News) - Belgian drug maker UCB has agreed to buy US-based clinical-stage biopharmaceuticals company Ra Pharmaceuticals for $2.1bn.
Europe close: Stocks mixed after BoE minutes, be... | 17-Dec-2014 | ShareCast |
GSK gets emerging markets boost with UCB deal | 24-Jan-2009 | Telegraph |
UCB confident on drug go-ahead | 21-Aug-2007 | The Scotsman |
Fellner shuffles Acambis board | 08-Mar-2007 | Telegraph |
Deal speeds drugs sector consolidation | 26-Sep-2006 | The Herald |
No recent information was found.
No recent information was found.
Currency | Euro |
Share Price | 137.85 |
Change Today | 1.90 |
% Change | 1.40 % |
52 Week High | 138.55 |
52 Week Low | 65.78 |
Volume | 265,472 |
Shares Issued | 194.51m |
Market Cap | 26,813m |
Beta | 0.90 |
Strong Buy | 8 |
Buy | 8 |
Neutral | 4 |
Sell | 1 |
Strong Sell | 0 |
Total | 21 |
Time | Volume / Share Price |
17:37 | 7 @ 137.85 |
17:37 | 7 @ 137.85 |
17:35 | 35 @ 137.85 |
17:35 | 58 @ 137.85 |
17:35 | 17 @ 137.85 |
You are here: research